Halozyme Therapeutics Inc. buy stratec
Start price
23.08.18
/
50%
€15.92
Target price
23.08.18
€24.35
Performance (%)
0.00%
End price
23.08.18
€15.92
Summary
This prediction ended on 23.08.18 with a price of €15.92. The BUY prediction by stratec closed unchanged from the start price. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Halozyme Therapeutics Inc. | 3.893% | 3.893% | 45.031% | 61.778% |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
Comments by stratec for this prediction
In the thread Halozyme Therapeu. diskutieren
HALO with many highly promising drugs are being developed in collaboration with strong partners.
Halozyme has delivered increasing profits for shareholders in the past year.
Halozyme is focused on the innovation and commercialization of novel oncology
medicines and drug deliveries. The company is powered by a robust pipeline of approved, partnered, and developing therapeutics.
(Vom Mitglied beendet)
Stopped prediction by stratec for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.48
23.08.18
23.08.18
€24.35
23.08.19
23.08.19
0.00%
23.08.19
23.08.19
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€15.92
23.08.18
23.08.18
€24.35
23.08.18
23.08.18
0.00%
23.08.18
23.08.18